Pathophysiology of IBS-D
IBS-D is a disorder of gut-brain interaction characterized by multiple interconnected pathophysiological mechanisms including altered gastrointestinal motility, low-grade mucosal inflammation with mast cell activation, visceral hypersensitivity, epithelial barrier dysfunction, and microbiome dysbiosis, all modulated by bidirectional gut-brain axis dysfunction. 1
Core Pathophysiological Mechanisms
Altered Transit and Motility
Patients with IBS-D demonstrate increased colonic motility with more high amplitude propagating contractions and accelerated colonic transit compared to other IBS subtypes 1. However, abnormal colonic transit occurs in only 25-45% of IBS-D patients, meaning the majority have normal transit despite symptoms 1. These high amplitude propagating contractions directly correlate with abdominal pain episodes 1.
The motility changes are influenced by elevated serotonin (5-HT) levels in IBS-D patients, contrasting with the low levels seen in constipation-predominant IBS 1. Recent mechanistic work reveals that stress-induced alterations in gut microbiota (specifically Lactobacillus murinus) produce spermidine, which suppresses type I interferon-α, thereby unrestricting colonic smooth muscle contractility 2.
Low-Grade Inflammation and Immune Activation
Increased mast cell numbers, particularly in the descending colon and rectosigmoid region, represent the most consistent histological finding in IBS-D 1. Mast cell hyperplasia is significantly more common in IBS-D than other subtypes 1. The severity and frequency of abdominal pain correlates with activated mast cells positioned close to nerve endings in the gut mucosa 1.
Beyond mast cells, plasma cell activation is elevated in IBS-D, with increased proximity to enteric nerve fibers 3. This humoral immune activation contributes directly to clinical manifestations and correlates with symptom severity 3. Low-grade inflammation can arise from prior infectious gastroenteritis (postinfection IBS), compromised epithelial barrier, dysbiosis, or altered stress responses 1, 4.
Epithelial Barrier Dysfunction
Glycocalyx thickness is significantly reduced in IBS-D patients, and this reduction correlates with plasma cell activation, proximity to nerves, and clinical symptom severity 3. Patients with elevated depressive symptoms show particularly pronounced increases in small intestinal permeability (s-IP) and circulating lipopolysaccharide levels, indicating endotoxin translocation 5. This barrier dysfunction creates a vicious cycle where increased permeability allows bacterial products to activate immune cells, perpetuating inflammation 4.
Visceral Hypersensitivity
Between 20-60% of IBS patients demonstrate enhanced visceral perception to mechanical or electrical stimuli 1. Hypersensitivity to mechanical gut distension is reported more frequently in IBS-D than constipation-predominant IBS 1. This hypersensitivity correlates positively with symptom severity even after adjusting for psychological comorbidity 1.
Gut-Brain Axis Dysfunction
IBS-D involves reduced parasympathetic activity and increased sympathetic nervous system activity 1. Reduced vagal tone, often stress-mediated, impacts gut motility, sensitivity, peripheral inflammation, and gut permeability 1.
Emerging neural circuit research demonstrates that enhanced activity of the medial prefrontal cortex-locus coeruleus glutamatergic circuit drives intestinal dysmotility in IBS-D 6. This provides a mechanistic link between central stress processing and peripheral gut dysfunction.
Microbiome Alterations
Strong evidence supports bacterial, viral, or parasitic infections triggering IBS 1. Dysbiosis is a key contributor to IBS-D pathogenesis 7, with changes in gut microbiome composition capable of modifying gastrointestinal motility, visceral sensation, intestinal permeability, and stool consistency 1. The stress-microbiome connection is particularly relevant, with stress inducing hyperproduction of xanthine and altering Lactobacillus murinus abundance and metabolic characteristics 2.
Clinical Implications
Common pitfall: Assuming all IBS-D patients have the same underlying pathophysiology. The condition represents a heterogeneous syndrome where different mechanisms predominate in different patients—some have primarily motility issues, others inflammatory changes, and many have overlapping mechanisms 4.
Key consideration: Psychological stress and early adverse life events predispose to IBS-D development 1, but psychological comorbidity may be consequence rather than cause in some patients 1. The relationship is bidirectional and varies individually.
The pathophysiology explains why symptoms correlate poorly with single objective measures—abdominal pain, bloating, and flatulence correlate poorly with colonic transit alone 1, requiring assessment of multiple pathophysiological domains for comprehensive understanding.